Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Hematologic malignancies: Selected abstracts and commentary
M. L. Grossbard
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hematologic malignancies: Selected abstracts and commentary'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hematological Malignancies
100%
Therapeutic Monoclonal Antibody
33%
Non-Hodgkin Lymphoma
33%
Disease Diagnosis
33%
Disease Management
33%
Clinical Development
33%
Targeted Therapy
33%
Chronic Myeloid Leukemia
33%
Positron Emission Tomography
33%
Rationally Designed
33%
Tyrosine Kinase Inhibitor
33%
New Advances
33%
STI571
33%
Antibody Therapy
33%
Lymphoid Malignancies
33%
Radioimmunoconjugate
33%
Unconjugated Antibody
33%
Medicine and Dentistry
Hematologic Malignancy
100%
Monoclonal Antibody
33%
Non-Hodgkin Lymphoma
33%
Tyrosine-Kinase Inhibitor
33%
Disease Management
33%
Targeted Therapy
33%
Chronic Myelogenous Leukemia
33%
Positron Emission Tomography
33%
Antibody Therapy
33%
Excitement
33%
Diseases
33%
Sexually Transmitted Infection
33%
Nursing and Health Professions
Hematologic Malignancy
100%
Disease Management
33%
Positron Emission Tomography
33%
Protein Tyrosine Kinase Inhibitor
33%
Monoclonal Antibody
33%
Chronic Myeloid Leukemia
33%
Nonhodgkin Lymphoma
33%
Disease Detection
33%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
100%
Diseases
66%
Nonhodgkin Lymphoma
33%
Monoclonal Antibody
33%
Protein Tyrosine Kinase Inhibitor
33%
Chronic Myeloid Leukemia
33%